Sidney M. Wolfe, M.D. v. Department of Health & Human Services

815 F.2d 1527, 259 U.S. App. D.C. 326
CourtCourt of Appeals for the D.C. Circuit
DecidedJuly 2, 1987
Docket86-5017
StatusPublished
Cited by13 cases

This text of 815 F.2d 1527 (Sidney M. Wolfe, M.D. v. Department of Health & Human Services) is published on Counsel Stack Legal Research, covering Court of Appeals for the D.C. Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sidney M. Wolfe, M.D. v. Department of Health & Human Services, 815 F.2d 1527, 259 U.S. App. D.C. 326 (D.C. Cir. 1987).

Opinions

Opinion for the court filed by Senior Circuit Judge J. SKELLY WRIGHT.

Dissenting opinion filed by Circuit Judge, BORK.

J. SKELLY WRIGHT, Senior Circuit Judge:

The plaintiffs-appellees, members of the Public Citizen Health Research Group, requested access under the Freedom of Information Act (FOIA), 5 U.S.C. § 552 et seq. (1982), to some of the information contained in a “Regulations Log” maintained by the Department of Health and Human Services (HHS). The Department refused plaintiffs’ requests, contending that the information sought was exempt under FOIA Exemption 5, which shields from disclosure those documents that would not be routinely available in civil litigation with the agency. The government claimed that the log information should be considered privileged and thus exempt under the deliberative process privilege. Although the government raised only the common law dimension of the privilege in the District Court, it raises the constitutional aspect of the privilege as well before this court. The District Court rejected the government’s argument, and we now address on appeal the proper scope of the privilege claimed and therefore of Exemption 5 as well.

I. Factual Background

Plaintiffs filed the instant FOIA request in order to locate the cause of what they allege to be unreasonable delay in issuance of Food and Drug Administration (FDA) regulations. This case is part of a larger attack by plaintiffs and other individuals and organizations on the increasing centralization of rulemaking authority within the Executive Branch. Two developments within the last six years have sparked this attack. First, in 1981 the Secretary of HHS withdrew the delegation of power to the FDA to issue regulations that it deemed in the public interest. Instead, such regulations now must first be reviewed and approved by the Secretary. See 21 C.F.R. § 5.11 (1985). Second, the President issued Executive Order 12291 (Feb. 17, 1981), which requires all agencies considering issuance of a rule to submit the rule for review by the Office of Management and Budget (OMB). OMB scrutinizes the rule for consistency with presidential policies and for cost efficiency. Thus, before a rule proposed by FDA may be issued it must be approved first by the Secretary of HHS and then by OMB.

In essence, plaintiffs wish to know how long rules proposed by FDA are spending at each stopping point along the approval route from FDA to HHS to OMB and back to HHS, so that they can identify and contest delays in issuance of FDA regulations. Plaintiffs began by submitting on July 18, 1984 a written request to HHS for access to records indicating which FDA proposals were then pending for review by HHS or OMB. HHS denied this request by letter dated August 23, 1984 on the ground that the information sought is exempt from disclosure under FOIA Exemption 5. Plaintiffs renewed their request by letter dated March 7,1985, to which they received no formal response. Plaintiffs then filed this action in the District Court on April 1, 1985. By letter dated April 16, 1985 plain[1529]*1529tiffs submitted to HHS a second request for the same information and in addition sought access to the dates of transmittal of proposed rules from FDA to HHS, from HHS to OMB, and from OMB back to HHS. On April 19, 1985 HHS denied this second request on the same ground as the denial of the first request. On April 25, 1985 plaintiffs appealed by letter their April 16 request. The appeal was formally denied on May 31, 1985. On June 14, 1985 plaintiffs amended their complaint in this action to include their second request.1

While plaintiffs’ case was pending in District Court, HHS disclosed that it maintains a Regulations Log that lists by title regulatory action proposed by FDA (and other branches of HHS), the date on which the action was received by HHS, and, if applicable, the date on which HHS sent it on to OMB. The log also contains information about the offices and persons within HHS to which the matter has been routed, but plaintiffs have not sought access to this information. Nor do plaintiffs seek access to the specific substance of the proposed rules. They seek only the dates on which the proposals, identified only by their title, were transmitted from one agency to another. This information will usually reveal whether and when FDA proposes rulemak-ing and whether and when such proposals are approved by HHS and OMB.

The District Court ruled that FOIA Exemption 5 did not apply to this case because the log information does not fall under the deliberative process privilege as the government claimed. District Judge Pratt reasoned that none of the policies underlying the privilege would be significantly implicated by disclosure of the requested material and concluded that the mere fact that “a recommendation has been made by one agency to another” is not information “sufficiently ‘deliberative’ to trigger the protections of the privilege.” Memorandum Opinion, 630 F.Supp. 546 (D.D.C.1985) (hereinafter Mem. Op.) at 550, Joint Appendix (JA) 79-80. Accordingly, the District Court granted summary judgment for plaintiffs, denied defendant’s cross-motion for summary judgment, and ordered disclosure of the requested information within 30 days. HHS filed a timely appeal, and on January 17, 1986 a panel of this court granted the agency’s unopposed motion for a stay of the District Court’s order pending appeal. For the reasons cogently set forth by the District Court and elaborated below, we affirm the grant of summary judgment to plaintiffs.

II. The Common Law Deliberative Process Privilege

The government relies heavily on appeal (and relied exclusively in the District Court) on the common law deliberative process privilege. This privilege, which shields predecisional advisory opinions and recommendations from disclosure, is uncontrovertedly meant to promote candor in governmental deliberations. Indeed, the legislative history of Exemption 5 states explicitly that the purpose of the exemption is to encourage “frank discussion of legal and policy issues.” S.Rep. No. 813, 89th Cong., 1st Sess. 9 (1965); see H.R.Rep. No. 1497, 89th Cong., 2d Sess. 10 (1966). In light of this clear purpose, the Supreme Court and this circuit have uniformly held that the privilege protects only predecisional opinion, not purely factual information that does not reveal the substance of predecisional opinion.2 See EPA v. Mink, 410 U.S. 73, 93 S.Ct. 827, 35 L.Ed.2d 119 [1530]*1530(1973); Coastal States Gas Corp. v. Dep’t of Energy, 617 F.2d 854 (D.C.Cir.1980); Ryan v. Dep’t of Justice, 617 F.2d 781 (D.C.Cir.1980).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Center for Biological Diversity v. Office of Management & Budget
625 F. Supp. 2d 885 (N.D. California, 2009)
In Re: Bruce Lindsey
148 F.3d 1100 (D.C. Circuit, 1998)
In Re Bruce R. Lindsey (Grand Jury Testimony)
158 F.3d 1263 (D.C. Circuit, 1998)
In Re Sealed Case
116 F.3d 550 (D.C. Circuit, 1997)
Wolfe v. Department of Health & Human Services
821 F.2d 809 (D.C. Circuit, 1987)

Cite This Page — Counsel Stack

Bluebook (online)
815 F.2d 1527, 259 U.S. App. D.C. 326, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sidney-m-wolfe-md-v-department-of-health-human-services-cadc-1987.